Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations? (Q34572576)

3 August 2017

title

Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations? (English)

1 reference

Erratum: Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?

3 August 2017

1 reference

1 reference

corrigendum / erratum

0 references

Cezary Cybulski

1 reference

3 August 2017

Jan Lubiński

1 reference

3 August 2017

Grzegorz Kurzawski

1 reference

3 August 2017

Tomasz Byrski

1 reference

3 August 2017

Steven A Narod

1 reference

3 August 2017

Tomasz Huzarski

1 reference

3 August 2017

Jacek Gronwald

1 reference

3 August 2017

Bohdan Górski

1 reference

3 August 2017

Dominika Wokołorczyk

1 reference

3 August 2017

Józef Kładny

1 reference

3 August 2017

Joanna Suchy

1 reference

3 August 2017

Ewa Grabowska

1 reference

3 August 2017

Tadeusz D Ecedil Bniak

series ordinal

1 reference

3 August 2017

publication date

15 November 2006

1 reference

European Journal of Human Genetics

3 August 2017

published in

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

237-241

1 reference

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

CHEK2 is a multiorgan cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

CHEK2 variant I157T may be associated with increased breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

A novel founder CHEK2 mutation is associated with increased prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Mutations in CHEK2 associated with prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Mutation analysis of the CHK2 gene in families with hereditary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

CHEK2 variants associate with hereditary prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

CHEK2 I157T associates with familial and sporadic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

CHEK2 1100delC and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Chk1 and Chk2 kinases in checkpoint control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Colorectal cancer and theCHEK2 1100delC mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

7 January 2021

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

7 January 2021

Association of two mutations in theCHEK2 gene with breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

7 January 2021

A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201734

7 January 2021

Identifiers

DOI

10.1038/SJ.EJHG.5201734

1 reference

3 August 2017

1 reference